Legal uncertainties in the DSCSA

The US Food and Drug Administration (FDA) faces a challenging schedule for implementing the Drug Supply Chain Security Act (DSCSA), enacted on Nov 27, 2013. The DSCSA revamps the requirements for securing prescription drugs throughout the supply chain, and mandates […]

Read More

Pharma in China–calculated risk gone wrong

Many government campaigns in China appear for a brief period and then disappear. President Xi Jinping's anti-corruption campaign, however, appears to have considerable staying power. Pres. Xi made it one of his cornerstone policies when he came to power, as […]

Read More

Six factors driving new specialty pharmacies

Specialty drugs will account for 50% of total US drug spending within five years. The projected growth is drawing many companies into the business of dispensing specialty drugs. The new entrants will increase competition and challenge manufacturers’ channel strategies. Here […]

Read More